The use of antibodies against the placental growth factor in the prophylactic setting in the pathophysiology of portal hypertensive mice

Christophe Van Steenkiste; Anja Geerts; Eline Vanheule; Hans Van Vlierberghe; Filip De Vos; Peter Carmeliet; Martine De Vos; Jean–Marie Stassen; Désiré Collen; Isabelle Colle

Back

The use of antibodies against the placental growth factor in the prophylactic setting in the pathophysiology of portal hypertensive mice

Article 2008 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2008

The use of antibodies against the placental growth factor as a new therapeutic target in the pathophysiology of portal hypertensive mice

Christophe Van Steenkiste, Anja Geerts, Eline Vanheule, Hans Van Vlierberghe, Filip De Vos, Peter Carmeliet, Martine De Vos, Jean–Marie Stassen, Désiré Collen, Isabelle Colle

Article2006

Placental growth factor plays a role in the mesenteric neo-angiogenesis of portal hypertensive mice

Anja Geerts, Eline Vanheule, Peter Carmeliet, Hans Van Vlierberghe, Luc Leybaert, Martine De Vos, Isabelle Colle

Article2008

Deficiency in placental growth factor causes a decreased portosystemic collateral vessel information in portal hypertensive mice

Christophe Van Steenkiste, Anja Geerts, Eline Vanheule, Hans Van Vlierberghe, Filip De Vos, Peter Carmeliet, Martine De Vos, Isabelle Colle

Article2008

264 DEFICIENCY IN PLACENTAL GROWTH FACTOR CAUSES A DECREASED PORTO-SYSTEMIC COLLATERAL VESSEL FORMATION IN PORTAL HYPERTENSIVE MICE

Christophe Van Steenkiste, Anja Geerts, Eline Vanheule, Hans Van Vlierberghe, Filip De Vos, Peter Carmeliet, Martine De Vos, Isabelle Colle

Article2003

Antibodies against placental growth factor prevent CO2 pneumoperitoneum-enhanced adhesion formation following laparoscopic surgery in mice

Carlos Roger Molinas, María Mercedes Binda, Peter Carmeliet, Philippe R. Koninckx